Globus Medical, Inc.

GMED · NYSE · ·

Karşılaştır

$72,14-%0,213 Kas kapanış

30 Eylül 2026 tarihine kadarki rakamlar, 5 Kasım 2026 tarihinde sunulan 10-Q raporundan

1W: +%1,5
1M: -%8,5

Just reported

Q3 2026 results

From Globus Medical's results release of 5 Kasım 2026; its quarterly report has since been filed.

Revenue
Actual
$763,7M
-%0,7 y/y
-%3,3 q/q
Guided
—
No guide given
EPS, GAAP
Actual
$1,04
+%18 y/y
-%5,5 q/q
Guided
—
No guide given
EPS, adjusted: $1,23
Operating income, GAAP
Actual
$177,6M
+%29 y/y
-%2,7 q/q
Guided
—
No guide given

Company outlook

Full year 2026

Revenue$3,09B+%5,1 y/y Lowered -%3,4
EPS, adjusted$4,95 – $5,05First given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes Globus Medical is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

Highest-graded in Medical Devices

Graded A or B and worth $2B or more: A first, then the largest.

All 132 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

Tüm finansal tablolar →

Globus Medical, Inc. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.

Globus Medical, Inc.

Globus Medical, Inc.

Q3 2026 results

Revenue

EPS, GAAP